Publication | Open Access

The Prevention of COVID-19 in High-Risk Patients Using Tixagevimab–Cilgavimab (Evusheld): Real-World Experience at a Large Academic Center

VaccinationPreventive MedicineLarge Academic CenterReal-world ExperienceTreatment And PreventionCovid-19 PandemicAntiviral TherapyCovid-19 EpidemiologyPublic HealthMedicineEpidemiologyCovid-19